Skip to main content
Premium Trial:

Request an Annual Quote

People in the News at Agilent Technologies, Ansa Biotechnologies, BostonGene, Cue Health

Agilent Technologies: Mike McMullen, Padraig McDonnell, Angelica Riemann, Jonah Kirkwood

Agilent Technologies' board of directors said that the company's CEO of nine years, Mike McMullen, is stepping down from that role on May 1, and he will become an adviser to the company until his retirement begins Oct. 31. He will be succeeded by Padraig McDonnell, who is currently the president of the Agilent CrossLab Group and the company's chief commercial officer. McMullen joined Agilent's predecessor company Hewlett-Packard in 1984 and rose through senior management positions until he took over as CEO from William Sullivan in March 2015. McDonnell also joined Agilent through Hewlett-Packard, which he began working for in 1998. He has been the president of the Agilent CrossLab Group since May 2020 and CCO since November 2021.

Angelica Riemann, VP and general manager of the Agilent CrossLab Group's CrossLab Services Division, will take over as the group's president. Jonah Kirkwood, VP of global sales, will take over as CCO and lead the One Agilent Commercial Organization.

Ansa Biotechnologies: Jason Gammack and Dan Lin-Arlow

Ansa Biotechnologies, a DNA synthesis technology company, has appointed Jason Gammack as CEO. Founding CEO Dan Lin-Arlow will remain with the company and transition to a new position as CSO.

Gammack has more than 30 years of life sciences industry experience. Most recently, he cofounded and was CEO of Resolve Biosciences, a multiplex spatial analysis firm. Prior to that, he was chief commercial officer at Inscripta. He has also held leadership positions at Qiagen, Ingenuity Systems, Sigma-Aldrich, Invitrogen/Life Technologies, Affymetrix, and Promega.

BostonGene: Joe Lennerz, Mark Hiatt, Ned Segal

BostonGene appointed Joe Lennerz as CSO, Mark Hiatt as senior VP of market access and strategy, and Ned Segal as a member of the board of directors.

Lennerz previously served as associate chief of pathology and medical director of the Center for Integrated Diagnostics at Massachusetts General Hospital and Harvard Medical School. Hiatt previously served as VP of medical affairs for Guardant Health, executive medical director for Regence BlueCross BlueShield, and chief medical officer for HealthHelp. Segal has previously served as CFO of Twitter, senior VP of finance at Intuit's Small Business Group, and as CFO at patent risk management company RPX. He most recently served as managing director and head of global software investment banking at Goldman Sachs and is a board member at RingCentral and Beyond Meat.

Cue Health: Rishi Reddy

Cue Health has appointed Rishi Reddy to its board of directors. Reddy is a managing director at Tarsadia Investments, leading the venture and growth equity strategy. Reddy was previously an observer on Cue's board from April 2018 to September 2021. Tarsadia is Cue's largest shareholder and has expressed concern about the direction of the company and its financial performance.

Before Tarsadia, Reddy was the founder and CEO of digital pathology firm DigiPath Solutions. 

Cue said it also expects to add an independent director to the board.

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the People in the News page on our website.